SHAREMachine Learning and AI have been the center of much hype over the past few years. This hype is not entirely unwarranted. But, we have also seen how these new technologies can be misused or used blindly, having a negative impact on the very people they are intended to help. This week, we see some good and some not-so-good news about ML & AI. Governance plays a key role in the equitable implementation of new technologies At HIMSS21, Kevin Ross…
SHARESHARE
SHARESHARE
SHARE“By 2020, the average person will have more conversations with bots than with their spouse”, predicts Heather Pemberton Levy in a recent Gartner report. If you’ve ever spoken with Amazon Alexa or Google Home, this prediction seems very possible. The impact on every aspect of health delivery is likely to be as profound. Here are our 5 predictions on how conversational agents will show up in clinics, hospitals, ALFs/SNFs, and patient homes. Yet one more Artificial Intelligence is going to…
SHAREYes, you read that correctly. Big pharma is teaming up with companies like Palo Alto based twoXAR to leverage artificial intelligence (AI) software to identify new drug candidates. Asian Liver Center of Stanford worked with twoXAR to screen 25,000 potential candidates for liver cancer. In four months, they came up with a treatment that’s headed for human trials. In comparison, the only FDA approved treatment for the same cancer took five years to get to the same point! Given the…
SHARENearly 50 years after the iconic film, 2001: A Space Odyssey, was released, the spine-chilling words, “I’m sorry Dave, I can’t do that.” live on. Spoken by the infamous, anthropomorphized computer, HAL 2000, the characterization—and potential dangers—of a seemingly flawed artificially intelligent machine, even today, remain an active topic of debate amongst the greatest, living minds on the 21st century. Artificial Intelligence aside (sorry HAL), traditional statistics and more recent paradigms such as machine learning are commercially used, today, for…
Top Rated on AppStore
Subscribe to receive our monthly newsletter and the latest industry news